Brian W. Pusch
About Brian W. Pusch
Brian W. Pusch is a co-founder and board member with extensive experience in the pharmaceutical and theater sectors. He has held leadership roles at Xiconic Pharmaceuticals LLC, Inozyme Pharma, and Oncovir, Inc., and previously served on the board of the American Globe Theatre.
Work at Inozyme Pharma
Brian W. Pusch has served as a Co-Founder at Inozyme Pharma since 2015. The company, based in Cambridge, Massachusetts, focuses on developing innovative therapies for rare diseases. Pusch's role involves strategic decision-making and guiding the company's vision and operations. His extensive experience in the pharmaceutical sector contributes to the company's mission of advancing treatment options for patients with unmet medical needs.
Work at Xiconic Pharmaceuticals LLC
Since 2018, Brian W. Pusch has held the position of Co-Founder and Member of the Board of Directors at Xiconic Pharmaceuticals LLC. Located in New York, New York, the company is dedicated to developing novel pharmaceutical solutions. Pusch's leadership and expertise play a crucial role in steering the company's strategic direction and fostering growth within the competitive pharmaceutical landscape.
Board Membership at Oncovir, Inc.
Brian W. Pusch has been a Member of the Board of Directors at Oncovir, Inc. since 2022. This organization, based in Winchester, Virginia, specializes in developing therapies for cancer treatment. Pusch's involvement on the board supports the company's strategic initiatives and enhances its commitment to advancing cancer care.
Previous Experience at American Globe Theatre
Brian W. Pusch served as a Board Member at the American Globe Theatre from 2006 to 2014. During his eight-year tenure in New York, NY, he contributed to the organization’s governance and strategic planning. His experience in the arts sector reflects his diverse interests and commitment to supporting cultural initiatives.
Education and Expertise
Brian W. Pusch earned an A.B. in Interdisciplinary Studies of Economics and Government from William & Mary, studying from 1972 to 1976. He furthered his education at the University of Virginia School of Law, where he obtained his Doctor of Law (J.D.) degree from 1976 to 1979. His academic background provides a strong foundation for his roles in both the pharmaceutical and nonprofit sectors.